{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T07:52:18Z","timestamp":1753602738087,"version":"3.38.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s12185-024-03909-7","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T15:06:38Z","timestamp":1736089598000},"page":"421-426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A case of late-onset sinusoidal obstruction syndrome diagnosed histologically before meeting diagnostic criteria"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6623-1862","authenticated-orcid":false,"given":"Takashi","family":"Kuroha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akane","family":"Kaihatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Usuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,5]]},"reference":[{"key":"3909_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","volume":"16","author":"JA Coppell","year":"2010","unstructured":"Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transpl. 2010;16:157\u201368.","journal-title":"Biol Blood Marrow Transpl"},{"key":"3909_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41409-019-0705-z","volume":"55","author":"M Mohty","year":"2020","unstructured":"Mohty M, Malard F, Abecasis M, Aerts E, Alaskar AS, Aljurf M, et al. Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a position statement from an international expert group. Bone Marrow Transpl. 2020;55:485\u201395.","journal-title":"Bone Marrow Transpl"},{"key":"3909_CR3","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/bmt.2016.130","volume":"51","author":"M Mohty","year":"2016","unstructured":"Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, et al. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transpl. 2016;51:906\u201312.","journal-title":"Bone Marrow Transpl"},{"key":"3909_CR4","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s41409-023-02077-2","volume":"58","author":"T Ruutu","year":"2023","unstructured":"Ruutu T, Peczynski C, Houhou M, Polge E, Mohty M, Kr\u00f6ger N, et al. Current incidence, severity, and management of veno-occlusive disease\/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT transplant complications working party study. Bone Marrow Transpl. 2023;58:1209\u201314.","journal-title":"Bone Marrow Transpl"},{"key":"3909_CR5","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.bbmt.2007.08.002","volume":"13","author":"E Carreras","year":"2007","unstructured":"Carreras E, Rosi\u00f1ol L, Terol MJ, Alegre A, de Arriba F, Garc\u00eda-Lara\u00f1a J, et al. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients. Biol Blood Marrow Transpl. 2007;13:1448\u201354.","journal-title":"Biol Blood Marrow Transpl"},{"key":"3909_CR6","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1182\/blood-2015-10-676924","volume":"127","author":"PG Richardson","year":"2016","unstructured":"Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S, Termuhlen AM, et al. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood. 2016;127:1656\u201365.","journal-title":"Blood"},{"key":"3909_CR7","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/bjh.15267","volume":"181","author":"NA Kernan","year":"2018","unstructured":"Kernan NA, Grupp S, Smith AR, Arai S, Triplett B, Antin JH, et al. Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease\/sinusoidal obstruction syndrome. Br J Haematol. 2018;181:816\u201327.","journal-title":"Br J Haematol"},{"key":"3909_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/bjh.14727","volume":"178","author":"PG Richardson","year":"2017","unstructured":"Richardson PG, Smith AR, Triplett BM, Kernan NA, Grupp SA, Antin JH, et al. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease\/sinusoidal obstruction syndrome improves day +100 survival following haematopoietic stem cell transplantation. Br J Haematol. 2017;178:112\u20138.","journal-title":"Br J Haematol"},{"key":"3909_CR9","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","volume":"16","author":"PG Richardson","year":"2010","unstructured":"Richardson PG, Soiffer RJ, Antin JH, Uno H, Jin Z, Kurtzberg J, et al. Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial. Biol Blood Marrow Transpl. 2010;16:1005\u201317.","journal-title":"Biol Blood Marrow Transpl"},{"key":"3909_CR10","doi-asserted-by":"publisher","first-page":"1050994","DOI":"10.3389\/fimmu.2022.1050994","volume":"13","author":"AB Moreno-Casta\u00f1o","year":"2022","unstructured":"Moreno-Casta\u00f1o AB, Salas MQ, Palomo M, Martinez-Sanchez J, Rovira M, Fern\u00e1ndez-Avil\u00e9s F, et al. Early vascular endothelial complications after hematopoietic cell transplantation: role of the endotheliopathy in biomarkers and target therapies development. Front Immunol. 2022;13:1050994.","journal-title":"Front Immunol"},{"key":"3909_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3389\/fimmu.2020.00489","volume":"11","author":"F Bonifazi","year":"2020","unstructured":"Bonifazi F, Barbato F, Ravaioli F, Sessa M, Defrancesco I, Arpinati M, et al. Diagnosis and treatment of VOD\/SOS after allogeneic hematopoietic stem cell transplantation. Front Immunol. 2020;11:489.","journal-title":"Front Immunol"},{"key":"3909_CR12","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41409-023-01992-8","volume":"58","author":"M Mohty","year":"2023","unstructured":"Mohty M, Malard F, Alaskar AS, Aljurf M, Arat M, Bader P, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). Bone Marrow Transpl. 2023;58:749\u201354.","journal-title":"Bone Marrow Transpl"},{"key":"3909_CR13","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/bjh.16557","volume":"190","author":"MS Cairo","year":"2020","unstructured":"Cairo MS, Cooke KR, Lazarus HM, Chao N. Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS\/VOD after haematopoietic cell transplantation. Br J Haematol. 2020;190:822\u201336.","journal-title":"Br J Haematol"},{"key":"3909_CR14","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/hep.1840190515","volume":"19","author":"HM Shulman","year":"1994","unstructured":"Shulman HM, Fisher LB, Schoch HG, Henne KW, McDonald GB. Venoocclusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology. 1994;19:1171\u201381.","journal-title":"Hepatology"},{"key":"3909_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12185-019-02660-8","volume":"110","author":"J Sugita","year":"2019","unstructured":"Sugita J. HLA-haploidentical stem cell transplantation using posttransplant cyclophosphamide. Int J Hematol. 2019;110:30\u20138.","journal-title":"Int J Hematol"},{"key":"3909_CR16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41409-018-0279-1","volume":"54","author":"J Sugita","year":"2018","unstructured":"Sugita J, Kagaya Y, Miyamoto T, Shibasaki Y, Nagafuji K, Ota S, et al. Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide. Bone Marrow Transpl. 2018;54:432\u201341.","journal-title":"Bone Marrow Transpl"},{"key":"3909_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF01695888","volume":"66","author":"E Carreras","year":"1993","unstructured":"Carreras E, Gra\u00f1ena A, Navasa M, Bruguera M, Marco V, Sierra J, et al. On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease. Ann Hematol. 1993;66:77\u201380.","journal-title":"Ann Hematol"},{"key":"3909_CR18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/bjh.12558","volume":"163","author":"FL Dignan","year":"2013","unstructured":"Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A, et al. BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol. 2013;163:444\u201357.","journal-title":"Br J Haematol"},{"key":"3909_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.diii.2013.08.009","volume":"95","author":"A Dohan","year":"2014","unstructured":"Dohan A, Guerrache Y, Boudiaf M, Gavini JP, Kaci R, Soyer P. Transjugular liver biopsy: indications, technique and results. Diagn Interv Imaging. 2014;95:11\u20135.","journal-title":"Diagn Interv Imaging"},{"key":"3909_CR20","doi-asserted-by":"publisher","first-page":"639.e1","DOI":"10.1016\/j.jtct.2023.06.023","volume":"29","author":"A Fukumoto","year":"2023","unstructured":"Fukumoto A, Honma K, Nakaminato S, Kitaura K, Ikeda D, Uesugi Y, et al. Concordance between HokUS-10 scoring and transjugular liver biopsy for the diagnosis of veno-occlusive disease\/sinusoidal obstruction syndrome after allogeneic stem cell transplantation. Transpl Cell Ther. 2023;29:639.e1-639.e4.","journal-title":"Transpl Cell Ther"},{"key":"3909_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jhep.2007.05.001","volume":"47","author":"G Kalambokis","year":"2007","unstructured":"Kalambokis G, Manousou P, Vibhakorn S, Marelli L, Cholongitas E, Senzolo M, et al. Transjugular liver biopsy \u2013 indications, adequacy, quality of specimens, and complications \u2013 a systematic review. J Hepatol. 2007;47:284\u201394.","journal-title":"J Hepatol"},{"key":"3909_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-0032-1312572","volume":"29","author":"G Behrens","year":"2012","unstructured":"Behrens G, Ferral H. Transjugular liver biopsy. Semin Intervent Radiol. 2012;29:111\u20137.","journal-title":"Semin Intervent Radiol"},{"key":"3909_CR23","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/s41409-020-01135-3","volume":"56","author":"A Hamid Bazarbachi","year":"2021","unstructured":"Hamid Bazarbachi A, Al Hamed R, Labopin M, Halaburda K, Labussiere H, Bernasconi P, et al. Underdiagnosed veno-occlusive disease\/sinusoidal obstruction syndrome (VOD\/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party. Bone Marrow Transpl. 2021;56:917\u201327.","journal-title":"Bone Marrow Transpl"},{"key":"3909_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41409-024-02215-4","volume":"59","author":"H Ichikawa","year":"2024","unstructured":"Ichikawa H, Yakushijin K, Kurata K, Tsuji T, Takemoto N, Joyce M, et al. Utility of the refined EBMT diagnostic and severity criteria 2023 for sinusoidal obstruction syndrome\/veno-occlusive disease. Bone Marrow Transpl. 2024;59:518\u201325.","journal-title":"Bone Marrow Transpl"},{"key":"3909_CR25","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1046\/j.1365-2141.2002.03748.x","volume":"118","author":"JH Lee","year":"2002","unstructured":"Lee JH, Lee KH, Lee JH, Kim S, Seol M, Park CJ, et al. Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide. Br J Haematol. 2002;118:1087\u201394.","journal-title":"Br J Haematol"},{"key":"3909_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/1024533031000084231","volume":"8","author":"M Kaleelrahman","year":"2003","unstructured":"Kaleelrahman M, Eaton JD, Leeming D, Bowyer K, Taberner D, Chang J, et al. Role of plasminogen activator inhibitor-1 (PAI-1) levels in the diagnosis of bmt-associated hepatic veno-occlusive disease and monitoring of subsequent therapy with defibrotide (DF). Hematology. 2003;8:91\u20135.","journal-title":"Hematology"},{"key":"3909_CR27","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.bbmt.2015.07.004","volume":"21","author":"A Akil","year":"2015","unstructured":"Akil A, Zhang Q, Mumaw CL, Raiker N, Yu J, de Velez MN, et al. Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation. Biol Blood Marrow Transpl. 2015;21:1739\u201345.","journal-title":"Biol Blood Marrow Transpl"},{"key":"3909_CR28","doi-asserted-by":"publisher","first-page":"166.e1","DOI":"10.1016\/j.jtct.2022.11.024","volume":"29","author":"S Putta","year":"2023","unstructured":"Putta S, Young BA, Levine JE, Reshef R, Nakamura R, Strouse C, et al. Prognostic biomarkers for hepatic veno-occlusive disease\/sinusoidal obstruction syndrome in myeloablative allogeneic hematopoietic cell transplantation: results from the blood and marrow transplant clinical trials network 1202 study. Transpl Cell Ther. 2023;29:166.e1-166.e10.","journal-title":"Transpl Cell Ther"},{"key":"3909_CR29","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.bbmt.2018.05.025","volume":"24","author":"M Nishida","year":"2018","unstructured":"Nishida M, Kahata K, Hayase E, Shigematsu A, Sato M, Kudo Y, et al. Novel ultrasonographic scoring system of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2018;24:1896\u2013900.","journal-title":"Biol Blood Marrow Transpl"},{"key":"3909_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10396-023-01392-x","volume":"51","author":"Y Inoue","year":"2024","unstructured":"Inoue Y, Saitoh S, Denpo H, Yamaguchi K, Kubota K, Taya Y, et al. Utility of liver stiffness measurement in the diagnosis of sinusoidal obstruction syndrome\/veno-occlusive disease after hematopoietic stem cell transplantation. J Med Ultrason. 2024;51:311\u201321.","journal-title":"J Med Ultrason"},{"key":"3909_CR31","doi-asserted-by":"publisher","first-page":"9241","DOI":"10.12998\/wjcc.v10.i26.9241","volume":"10","author":"YW Tan","year":"2022","unstructured":"Tan YW, Shi YC. Early diagnostic value of liver stiffness measurement in hepatic sinusoidal obstruction syndrome induced by hematopoietic stem cell transplantation. World J Clin Cases. 2022;10:9241\u201353.","journal-title":"World J Clin Cases"},{"key":"3909_CR32","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.bbmt.2019.01.019","volume":"25","author":"A Colecchia","year":"2019","unstructured":"Colecchia A, Ravaioli F, Sessa M, Alemanni VL, Dajti E, Marasco G, et al. Liver stiffness measurement allows early diagnosis of veno-occlusive disease\/sinusoidal obstruction syndrome in adult patients who undergo hematopoietic stem cell transplantation: results from a monocentric prospective study. Biol Blood Marrow Transpl. 2019;25:995\u20131003.","journal-title":"Biol Blood Marrow Transpl"},{"key":"3909_CR33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1148\/radiology.204.2.9240551","volume":"204","author":"N Lassau","year":"1997","unstructured":"Lassau N, Lecl\u00e8re J, Auperin A, Bourhis JH, Hartmann O, Valteau-Couanet D, et al. Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients. Radiology. 1997;204:545\u201352.","journal-title":"Radiology"},{"key":"3909_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s00247-021-05174-w","volume":"52","author":"AE Bohte","year":"2022","unstructured":"Bohte AE, Dierselhuis MP, van Noesel MM, Lequin MH. Imaging features of hepatic sinusoidal obstruction syndrome or veno-occlusive disease in children. Pediatr Radiol. 2022;52:122\u201333.","journal-title":"Pediatr Radiol"},{"key":"3909_CR35","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.bbmt.2013.04.005","volume":"19","author":"AR Rezvani","year":"2013","unstructured":"Rezvani AR, McCune JS, Storer BE, Batchelder A, Kida A, Deeg HJ, et al. Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes. Biol Blood Marrow Transpl. 2013;19:1033\u20139.","journal-title":"Biol Blood Marrow Transpl"},{"key":"3909_CR36","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.bbmt.2007.03.012","volume":"13","author":"JS McCune","year":"2007","unstructured":"McCune JS, Batchelder A, Deeg HJ, Gooley T, Cole S, Phillips B, et al. Cyclophosphamide following targeted oral busulfan as conditioning for hematopoietic cell transplantation: pharmacokinetics, liver toxicity, and mortality. Biol Blood Marrow Transpl. 2007;13:853\u201362.","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03909-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-024-03909-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03909-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T12:42:57Z","timestamp":1740487377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-024-03909-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["3909"],"URL":"https:\/\/doi.org\/10.1007\/s12185-024-03909-7","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2025,1,5]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}